Ameriprise
MRNS

Ameriprise’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Ameriprise’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-12,781
Closed -$116K – 3974
2024
Q1 		$116K Buy
+12,781
New +$124K ﹤0.01% 3767
2020
Q3 		– Sell
-2,550
Closed -$26K – 3804
2020
Q2 		$26K Sell
2,550
-51
-2% -$469 ﹤0.01% 3639
2020
Q1 		$21K Buy
+2,601
New +$22.5K ﹤0.01% 3609

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ameriprise's MRNS Position: Q2 2024 in Review

Ameriprise sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 12,781 shares — an estimated $116K sold.

Ameriprise first reported a position in MRNS in Q1 2020 and held it in 3 quarters. The position peaked at $116K in Q1 2024. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Ameriprise reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 12,781 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $116K.
  • Ameriprise first reported a position in Marinus Pharmaceuticals, Inc in Q1 2020 and held it in 3 quarters.
  • Ameriprise's Marinus Pharmaceuticals, Inc position peaked at $116K in Q1 2024.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.